Analyst Ratings for GlaxoSmithKline (GSK)
GSK Rating Summary
GSK Price Target Summary
- Highest: $70.00 (TD Cowen)
- Lowest: $53.00 (CFRA)
- Average: $64.02
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$64.02 (+29.3%)
* Over Last 12-Mos
Rating Score: 3.2 / 10
Percentile Rank: 27%
Avg. $ Target:
$64.02 (+29.3%)
* Over Last 12-Mos
Rating Score: 3.2 / 10
Percentile Rank: 27%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/9/2026 | Wolfe Research | Alexandria Hammond | New Coverage | Outperform (N/A) |
70.00 (N/A) |
46.54 (49.51) |
6.38% | Details |
| 9/15/2026 | Berenberg | Kerry Holford | Upgrade | Buy (Hold) |
60.00 (54.00) |
48.13 (49.51) |
2.87% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
